Logo image of OCI.AS

OCI NV (OCI.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:OCI - NL0010558797 - Common Stock

3.396 EUR
+0.04 (+1.07%)
Last: 11/28/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, OCI scores 4 out of 10 in our fundamental rating. OCI was compared to 74 industry peers in the Chemicals industry. While OCI is still in line with the averages on profitability rating, there are concerns on its financial health. OCI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year OCI was profitable.
OCI had a negative operating cash flow in the past year.
In multiple years OCI reported negative net income over the last 5 years.
OCI had a positive operating cash flow in each of the past 5 years.
OCI.AS Yearly Net Income VS EBIT VS OCF VS FCFOCI.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

1.2 Ratios

OCI has a Return On Assets of 140.76%. This is amongst the best in the industry. OCI outperforms 100.00% of its industry peers.
With an excellent Return On Equity value of 267.17%, OCI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
ROA 140.76%
ROE 267.17%
ROIC N/A
ROA(3y)41.1%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
OCI.AS Yearly ROA, ROE, ROICOCI.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200

1.3 Margins

OCI has a Profit Margin of 510.59%. This is amongst the best in the industry. OCI outperforms 100.00% of its industry peers.
OCI's Profit Margin has improved in the last couple of years.
The Gross Margin of OCI (0.21%) is worse than 87.84% of its industry peers.
OCI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 510.59%
GM 0.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
OCI.AS Yearly Profit, Operating, Gross MarginsOCI.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400 500

3

2. Health

2.1 Basic Checks

OCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OCI has about the same amount of shares outstanding.
OCI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for OCI has been reduced compared to a year ago.
OCI.AS Yearly Shares OutstandingOCI.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
OCI.AS Yearly Total Debt VS Total AssetsOCI.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

OCI has an Altman-Z score of 0.90. This is a bad value and indicates that OCI is not financially healthy and even has some risk of bankruptcy.
OCI has a Altman-Z score of 0.90. This is amonst the worse of the industry: OCI underperforms 81.08% of its industry peers.
OCI has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
OCI's Debt to Equity ratio of 0.05 is amongst the best of the industry. OCI outperforms 89.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 0.9
ROIC/WACCN/A
WACC7.94%
OCI.AS Yearly LT Debt VS Equity VS FCFOCI.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.65 indicates that OCI should not have too much problems paying its short term obligations.
OCI has a Current ratio (1.65) which is in line with its industry peers.
A Quick Ratio of 1.61 indicates that OCI should not have too much problems paying its short term obligations.
OCI has a Quick ratio of 1.61. This is in the better half of the industry: OCI outperforms 71.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.61
OCI.AS Yearly Current Assets VS Current LiabilitesOCI.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1368.28% over the past year.
The Earnings Per Share has been growing by 105.88% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 3.00% in the past year.
OCI shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -20.30% yearly.
EPS 1Y (TTM)1368.28%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%3950%
Revenue 1Y (TTM)3%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-53.2%

3.2 Future

The Earnings Per Share is expected to grow by 60.21% on average over the next years. This is a very strong growth
OCI is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -14.70% yearly.
EPS Next Y752.38%
EPS Next 2Y185.73%
EPS Next 3Y44.53%
EPS Next 5Y60.21%
Revenue Next Year-30.34%
Revenue Next 2Y-14.87%
Revenue Next 3Y-25.89%
Revenue Next 5Y-14.7%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OCI.AS Yearly Revenue VS EstimatesOCI.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
OCI.AS Yearly EPS VS EstimatesOCI.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 0.17, the valuation of OCI can be described as very cheap.
Based on the Price/Earnings ratio, OCI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
OCI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.31.
A Price/Forward Earnings ratio of 9.64 indicates a reasonable valuation of OCI.
89.19% of the companies in the same industry are more expensive than OCI, based on the Price/Forward Earnings ratio.
OCI is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.59, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 0.17
Fwd PE 9.64
OCI.AS Price Earnings VS Forward Price EarningsOCI.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OCI.AS Per share dataOCI.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as OCI's earnings are expected to grow with 44.53% in the coming years.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y185.73%
EPS Next 3Y44.53%

0

5. Dividend

5.1 Amount

No dividends for OCI!.
Industry RankSector Rank
Dividend Yield N/A

OCI NV

AMS:OCI (11/28/2025, 7:00:00 PM)

3.396

+0.04 (+1.07%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-13 2025-11-13
Earnings (Next)03-12 2026-03-12/amc
Inst Owners35.33%
Inst Owner ChangeN/A
Ins Owners8.71%
Ins Owner ChangeN/A
Market Cap717.78M
Revenue(TTM)975.10M
Net Income(TTM)4.98B
Analysts71.67
Price Target6.06 (78.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend13.18
Dividend Growth(5Y)N/A
DP84.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-16.25%
PT rev (3m)-25.02%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)25.16%
EPS NY rev (3m)28.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)0.4%
Valuation
Industry RankSector Rank
PE 0.17
Fwd PE 9.64
P/S 0.85
P/FCF N/A
P/OCF N/A
P/B 0.45
P/tB 0.45
EV/EBITDA N/A
EPS(TTM)20.4
EY600.71%
EPS(NY)0.35
Fwd EY10.38%
FCF(TTM)-1.08
FCFYN/A
OCF(TTM)-1.67
OCFYN/A
SpS3.99
BVpS7.62
TBVpS7.53
PEG (NY)0
PEG (5Y)N/A
Graham Number59.15
Profitability
Industry RankSector Rank
ROA 140.76%
ROE 267.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 510.59%
GM 0.21%
FCFM N/A
ROA(3y)41.1%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
F-Score4
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 241.89%
Cap/Sales 14.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.65
Quick Ratio 1.61
Altman-Z 0.9
F-Score4
WACC7.94%
ROIC/WACCN/A
Cap/Depr(3y)137.7%
Cap/Depr(5y)97.09%
Cap/Sales(3y)24.99%
Cap/Sales(5y)17.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1368.28%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%3950%
EPS Next Y752.38%
EPS Next 2Y185.73%
EPS Next 3Y44.53%
EPS Next 5Y60.21%
Revenue 1Y (TTM)3%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-53.2%
Revenue Next Year-30.34%
Revenue Next 2Y-14.87%
Revenue Next 3Y-25.89%
Revenue Next 5Y-14.7%
EBIT growth 1Y44.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year146.37%
EBIT Next 3Y-14.94%
EBIT Next 5Y-4.61%
FCF growth 1Y-119.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-121.07%
OCF growth 3Y-68.9%
OCF growth 5Y-27.39%

OCI NV / OCI.AS FAQ

What is the ChartMill fundamental rating of OCI NV (OCI.AS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to OCI.AS.


What is the valuation status for OCI stock?

ChartMill assigns a valuation rating of 6 / 10 to OCI NV (OCI.AS). This can be considered as Fairly Valued.


What is the profitability of OCI stock?

OCI NV (OCI.AS) has a profitability rating of 4 / 10.


What is the expected EPS growth for OCI NV (OCI.AS) stock?

The Earnings per Share (EPS) of OCI NV (OCI.AS) is expected to grow by 752.38% in the next year.


Is the dividend of OCI NV sustainable?

The dividend rating of OCI NV (OCI.AS) is 0 / 10 and the dividend payout ratio is 84.62%.